First Quadrant’s Utah Medical Products UTMD Stock Holding History

First Quadrant’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,456	Closed	-$346K	–	509
2021 Q4	$346K	Buy	3,456 +375	+12%	+$38.3K	0.04%	289
2021 Q3	$286K	Buy	3,081 +2,733	+785%	+$241K	0.03%	303
2021 Q2	$30K	Buy	+348	New	+$30.1K	﹤0.01%	456
2018 Q1	–	Sell	-3,745	Closed	-$305K	–	930
2017 Q4	$305K	Hold	3,745	–	–	0.01%	651
2017 Q3	$275K	Sell	3,745 -1,453	-28%	-$104K	0.01%	655
2017 Q2	$376K	Sell	5,198 -518	-9%	-$34.1K	0.01%	590
2017 Q1	$356K	Hold	5,716	–	–	0.01%	581
2016 Q4	$416K	Buy	5,716 +1,230	+27%	+$80K	0.01%	558
2016 Q3	$268K	Buy	+4,486	New	+$285K	0.01%	610

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

First Quadrant's UTMD Position: Q1 2022 in Review

First Quadrant sold out of Utah Medical Products (UTMD) in Q1 2022, closing a stake of 3,456 shares — an estimated $346K sold.

First Quadrant first reported a position in UTMD in Q3 2016 and held it in 9 quarters. The position peaked at $416K in Q4 2016. 85 funds tracked by Wall St. Rank hold UTMD as of Q1 2022.

First Quadrant reported no remaining Utah Medical Products position as of Q1 2022 after selling out during the quarter.
First Quadrant sold 3,456 Utah Medical Products shares in Q1 2022, an estimated $346K.
First Quadrant first reported a position in Utah Medical Products in Q3 2016 and held it in 9 quarters.
First Quadrant's Utah Medical Products position peaked at $416K in Q4 2016.
85 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.